Cargando…

A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis

Post-COVID-19 pulmonary fibrosis (PCPF) is a long-term complication that appears in some COVID-19 survivors. However, there are currently limited options for treating PCPF patients. To address this problem, we investigated COVID-19 patients’ transcriptome at single-cell resolution and combined biolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Albert, Chen, Jhih-Yu, Hsu, Chia-Lang, Oyang, Yen-Jen, Huang, Hsuan-Cheng, Juan, Hsueh-Fen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147547/ https://www.ncbi.nlm.nih.gov/pubmed/35631558 http://dx.doi.org/10.3390/pharmaceutics14050971

Ejemplares similares

A Large-Scale Gene Expression Intensity-Based Similarity Metric for Drug Repositioning
por: Huang, Chen-Tsung, et al.
Publicado: (2018)

BIC: a database for the transcriptional landscape of bacteria in cancer
por: Chen, Kai-Pu, et al.
Publicado: (2022)

Stratification of lncRNA modulation networks in breast cancer
por: Yu, Wen-Hsuan, et al.
Publicado: (2022)

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 Treatment
por: Tsai, Ming-Ju, et al.
Publicado: (2023)

Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery
por: Huang, Chen-Tsung, et al.
Publicado: (2019)

MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma
por: Huang, Chen-Tsung, et al.
Publicado: (2014)

Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy
por: Lin, Chen-Ching, et al.
Publicado: (2010)

MicroRNA-Regulated Protein-Protein Interaction Networks and Their Functions in Breast Cancer
por: Lee, Chia-Hsien, et al.
Publicado: (2013)

Crosstalk between transcription factors and microRNAs in human protein interaction network
por: Lin, Chen-Ching, et al.
Publicado: (2012)

Dr AFC: drug repositioning through anti-fibrosis characteristic
por: Wu, Dingfeng, et al.
Publicado: (2020)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Modular signature of long non-coding RNA association networks as a prognostic biomarker in lung cancer
por: Li, Albert, et al.
Publicado: (2021)

A review of validation strategies for computational drug repositioning
por: Brown, Adam S, et al.
Publicado: (2016)

Functional Analysis and Characterization of Differential Coexpression Networks
por: Hsu, Chia-Lang, et al.
Publicado: (2015)

Knowledge Mapping of Drug Repositioning’s Theme and Development
por: Lang, Xiaona, et al.
Publicado: (2023)

Network module‐based drug repositioning for pulmonary arterial hypertension
por: Wang, Rui‐Sheng, et al.
Publicado: (2021)

Repositioning of new potential schistosomicidal drugs using chemogenomic strategy
por: Duarte, Arthur Scalzitti, et al.
Publicado: (2014)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
por: Imakura, Takeshi, et al.
Publicado: (2023)

Quantitative Phosphoproteomics Reveals Cell Alignment and Mitochondrial Length Change under Cyclic Stretching in Lung Cells
por: Wang, Wei-Hsuan, et al.
Publicado: (2020)

The pulmonary route as a way to drug repositioning in COVID-19 therapy
por: Sarcinelli, Michelle Alvares, et al.
Publicado: (2021)

Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
por: Hsu, Chia-Lang, et al.
Publicado: (2016)

Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015)

Overcoming Mycobacterium tuberculosis Drug Resistance: Novel Medications and Repositioning Strategies
por: Sachan, Rohan Samir Kumar, et al.
Publicado: (2023)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation
por: Chang, Hao-Chun, et al.
Publicado: (2019)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
por: Jarada, Tamer N., et al.
Publicado: (2020)

Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations
por: Aleo, Serena J, et al.
Publicado: (2020)

Recent computational drug repositioning strategies against SARS-CoV-2
por: Lu, Lu, et al.
Publicado: (2022)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b8m8c3i3nmf7bpfvjemhqf6o9i